8-K: Centene Reaffirms 2024 Earnings Guidance at Barclays Healthcare Conference

Centene Corporation expects to reaffirm its 2024 adjusted diluted earnings per share guidance of greater than $6.70 during a presentation at the Barclays 26th Annual Global Healthcare Conference.

Summary

• Centene Corporation will present at the Barclays 26th Annual Global Healthcare Conference on March 12, 2024.
• The company expects to reaffirm its 2024 adjusted diluted earnings per share (EPS) guidance of greater than $6.70.
• A live audio webcast of the presentation will be available on the company's website.
• The company uses non-GAAP financial measures to assess its performance and believes these measures are helpful for investors.
• The company cautions that non-GAAP measures may differ from those used by other companies.
• The company is unable to provide a reconciliation of its 2024 adjusted diluted EPS guidance to the most directly comparable GAAP financial measure without unreasonable effort.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company is reaffirming its guidance, which is a good sign. However, the inability to reconcile non-GAAP measures and the numerous risk factors mentioned temper the overall positive sentiment.

Positives

• The company is reaffirming its previously issued 2024 adjusted diluted EPS guidance, indicating confidence in its financial outlook.
• The live webcast of the presentation provides transparency and accessibility for investors.

Negatives

• The company is unable to provide a reconciliation of its 2024 adjusted diluted EPS guidance to the most directly comparable GAAP financial measure, which may make it difficult for some investors to fully assess the company's performance.

Risks

• The company's future performance is subject to various risks and uncertainties, including changes in healthcare practices, competition, and regulatory changes.
• The company's ability to maintain or improve CMS Star ratings can impact revenue and future growth.
• The company faces risks related to managing health benefits and other operating expenses.
• The company's performance is subject to economic, social, and political conditions and geopolitical events.
• The company's performance is subject to changes in federal or state laws or regulations.
• The company's performance is subject to the difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings or matters.
• The company's performance is subject to cyber-attacks or other data security incidents.
• The company's performance is subject to losses in its investment portfolio.
• The company's performance is subject to restrictions and limitations in connection with its indebtedness.

Future Outlook

The company expects to reaffirm its 2024 adjusted diluted EPS guidance of greater than $6.70.

Management Comments

• The company believes that non-GAAP financial measures are helpful in allowing investors to more accurately assess the ongoing nature of the company's operations.
• The company uses non-GAAP financial measures internally in evaluating the company's performance and for planning purposes.

Industry Context

This announcement is typical for a healthcare company providing updates on its financial outlook at an industry conference. Reaffirming guidance is a positive signal to the market.

Comparison to Industry Standards

• Many large healthcare companies provide annual EPS guidance, so Centene's reaffirmation is consistent with industry practice.
• Companies like UnitedHealth Group and CVS Health also participate in similar healthcare conferences and provide financial updates.
• The use of non-GAAP measures is common in the healthcare industry to provide a clearer picture of core operating performance, but the lack of GAAP reconciliation is a point of concern.

Stakeholder Impact

• Shareholders will likely view the reaffirmation of earnings guidance positively.
• The webcast provides transparency for investors.
• The company's performance impacts employees, customers, and other stakeholders.

Next Steps

• Centene will present at the Barclays 26th Annual Global Healthcare Conference on March 12, 2024.
• A live audio webcast of the presentation will be available on the company's website.

Key Dates

Keywords

earnings per share, EPS, guidance, healthcare, non-GAAP, financial performance, webcast, Centene, conference